Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity

被引：3
作者：
Choi, Sung Hee [1 ,2 ]
Myers, Jay Thomas [1 ]
Tomchuck, Suzanne Louise [1 ]
Bonner, Melissa [3 ]
Eid, Saada [1 ]
Kingsley, Daniel Tyler [3 ]
Vanheyst, Kristen Ashley [1 ,2 ]
Kim, Seong-Jin [4 ]
Kim, Byung-Gyu [1 ,2 ]
Huang, Alex Yee-Chen [1 ,2 ,3 ,5 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH USA
[2] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH USA
[4] MedPacto Inc, Seoul, South Korea
[5] Rainbow Babies & Childrens Hosp, Angie Fowler AYA Canc Inst, Ctr Pediat Immunotherapy, Cleveland, OH USA
来源：
CANCER COMMUNICATIONS | 2024年 / 44卷 / 08期
关键词：
D O I：
10.1002/cac2.12589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：884 / 888
页数：5
相关论文
共 50 条
  • [21] Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis
    Kai-Da Wu
    Li Zhou
    Douglas Burtrum
    Dale L. Ludwig
    Malcolm A. S. Moore
    Cancer Immunology, Immunotherapy, 2007, 56 : 343 - 357
  • [22] Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas
    Ikeda, Hidetoshi
    BRAIN TUMOR PATHOLOGY, 2006, 23 (01) : 7 - 12
  • [23] Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer
    Im, Jin S.
    Herrmann, Amanda C.
    Bernatchez, Chantale
    Haymaker, Cara
    Molldrem, Jeffrey J.
    Hong, Waun Ki
    Perez-Soler, Roman
    PLOS ONE, 2016, 11 (07):
  • [24] Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (RENCA) cells
    Engel, JD
    Kundu, SD
    Yang, T
    Yang, S
    Goodwin, S
    Janulis, L
    Cho, JS
    Chang, J
    Kim, SJ
    Lee, C
    UROLOGY, 1999, 54 (01) : 164 - 170
  • [25] Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas
    Hidetoshi Ikeda
    Brain Tumor Pathology, 2006, 23 : 7 - 12
  • [26] Proteolysis targeting chimera (PROTAC) for epidermal growth factor receptor enhances anti-tumor immunity in non-small cell lung cancer
    Wang, Kai
    Zhou, Hongping
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (03) : 422 - 429
  • [27] ANTI-TUMOR EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR ON ORAL SQUAMOUS CELL CARCINOMA CELL LINES
    Han, Se-Jin
    Lee, Jae-Hoon
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2009, 35 (02) : 66 - 73
  • [28] Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population
    Yun-Sheng Hu
    Yong Pan
    Wen-Hai Li
    Yong Zhang
    Jun Li
    Bao-An Ma
    Medical Oncology, 2011, 28 : 622 - 625
  • [29] INTERLEUKIN-1-BETA INDUCES TUMOR NECROSIS AND EARLY MORPHOLOGIC AND METABOLIC CHANGES IN TRANSPLANTABLE MOUSE-TUMORS - SIMILARITIES WITH THE ANTI-TUMOR EFFECTS OF TUMOR NECROSIS FACTOR-ALPHA OR FACTOR-BETA
    BELARDELLI, F
    PROIETTI, E
    CIOLLI, V
    SESTILI, P
    CARPINELLI, G
    DEVITO, M
    FERRETTI, A
    WOODROW, D
    BORASCHI, D
    PODO, F
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) : 116 - 123
  • [30] Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis
    Yang, Guang-Wei
    Jiang, Jin-Song
    Lu, Wei-Qin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (10): : 24011 - 24031
12345